Economic burden of illness imposed by severe sepsis in Austria

Wiener Klinische Wochenschrift

Volumn 114, Issue 15-16, 2002, Pages 697-701

  Schmid, Alexandra ^a   Schneider, Heinz ^a   Adlof, Astrid ^a   Smolle, Karl Heinz ^a   Edelmann, Günther ^a   Sporn, Paul ^a   Frass, Michael ^a   Sumann, Günther ^a   Koller, Wolfgang ^a   Schobersberger, Wolfgang ^a  

^a Univ Klinik für Psychiatrie   (Austria)

Author keywords

Cost of disease; Cost of treatment; Health care costs; Intensive care; Sepsis

Indexed keywords

ARTICLE; AUSTRIA; CONTROLLED STUDY; DISEASE SEVERITY; ECONOMIC EVALUATION; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH ECONOMICS; HOSPITAL COST; HOSPITALIZATION; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PRODUCTIVITY; SEPSIS; WORK CAPACITY;

ADULT; AGED; AUSTRIA; COSTS AND COST ANALYSIS; FEMALE; HEALTH CARE COSTS; HEALTH RESOURCES; HUMANS; INTENSIVE CARE; LENGTH OF STAY; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 6444244497     PISSN: 00435325     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
2. Direct costs of severe sepsis patients in three German intensive care units based on retrospective electronic patient record analysis of resource use
3. A review of costs studies in intensive care units: Problems with the cost concept
4. Economic analysis of the intensive care unit: A dilemina
5. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
6. Statistik Austria
7. Statistik Austria
8. Statistisches bundesamt Deutschland
9. The use of the bootstrap statistical method for the pharmacoeconomic cost analysis of skewed data
10. In search of power and significance: Issues in design and analysis of stochastic cost-effectiveness studies in health care
11. Analysis and interpretation of cost data in randomised controlled trials: Review of published data
12. Cost of illness studies: A major headache?
13. Burden of illness imposed by severe sepsis in Germany
14. Efficacy and safety of recombinant human activated protein C for severe sepsis
15. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: A randomized controlled trial
16. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: A randomized controlled trial
17. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study